HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Intrauterine hypoxia — Clinical Guidelines

Overview

Intrauterine hypoxia, often associated with intrauterine growth restriction (IUGR), refers to inadequate oxygen supply to the fetus during gestation, potentially leading to fetal compromise, neonatal morbidity, and long-term developmental issues. 1 6 19

Diagnosis

Key Diagnostic Criteria: Small for gestational age (SGA), abnormal umbilical artery Doppler velocimetry, and maternal perception of decreased fetal movements. 10 18

Recommended Tests:

- Umbilical artery Doppler: To assess placental function. 10 18 - Uterine artery Doppler: To evaluate maternal placental circulation. 10 - Middle cerebral artery Doppler: For fetal brain perfusion assessment. 10 - Ductus venosus Doppler: To aid in timing delivery for severely growth-restricted fetuses. 10

Grading: Often assessed through clinical criteria and Doppler ultrasound findings, with severity graded based on the degree of restriction and associated complications. 6 10

Management

First-Line Treatments:

- Close Monitoring: Regular antenatal visits, fetal growth assessments, and Doppler ultrasound evaluations. 15 18 - Optimizing Maternal Health: Managing maternal conditions like hypertension, diabetes, and anemia. 16

Adjunctive Treatments:

- Antenatal Corticosteroids: For suspected preterm delivery to enhance fetal lung maturity, particularly relevant in growth-restricted fetuses. 8 - Nutritional Interventions: Supplementation with protein, vitamins, minerals, and fish oils, though evidence varies. 16 - Growth Hormone Therapy: Considered in cases of persistent short stature post-IUGR, especially in prepubertal children. 17

Special Populations

Pregnancy: Focus on optimizing placental function through close monitoring and management of maternal conditions. 15 16

Pediatrics: Address catch-up growth with growth hormone therapy in children with persistent short stature post-IUGR. 13 17

Comorbidities: Management of associated conditions like maternal undernutrition and placental insufficiency is crucial. 9 11

Key Recommendations

Utilize Doppler Ultrasound for regular assessment of placental function and fetal well-being in suspected IUGR cases. (Evidence: Strong 10 18)

Consider Antenatal Corticosteroids for growth-restricted fetuses at risk of preterm delivery to improve neonatal outcomes. (Evidence: Moderate 8)

Implement Close Antenatal Monitoring including frequent ultrasounds and clinical assessments to guide management decisions. (Evidence: Strong 15 18)

Evaluate Maternal Nutritional Status and intervene with appropriate supplementation to mitigate risks of IUGR, though efficacy varies. (Evidence: Moderate 16)

Monitor for Catch-Up Growth in pediatric patients post-IUGR and consider growth hormone therapy if necessary. (Evidence: Moderate 13 17)

References

1 Psilopatis I, Bader S, Krueckel A, Kehl S, Beckmann MW, Emons J. Can Chat-GPT read and understand guidelines? An example using the S2k guideline intrauterine growth restriction of the German Society for Gynecology and Obstetrics. Archives of gynecology and obstetrics 2024. link 2 Abdallah HR, Abdelrazek AA, Youness ER, Orban HA, Mahmoud MA, El Sayed AH et al.. Assessment of vitamin status; A, E and D in Egyptian neonates with IUGR: a cross sectional study. BMC pediatrics 2024. link 3 Nippita S, Haviland MJ, Voit SF, Perez-Peralta J, Hacker MR, Paul ME. Randomized trial of high- and low-fidelity simulation to teach intrauterine contraception placement. American journal of obstetrics and gynecology 2018. link 4 Lemley CO, Vonnahme KA. PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Alterations in uteroplacental hemodynamics during melatonin supplementation in sheep and cattle. Journal of animal science 2017. link 5 Haeussner E, Schmitz C, Frank HG, Edler von Koch F. Novel 3D light microscopic analysis of IUGR placentas points to a morphological correlate of compensated ischemic placental disease in humans. Scientific reports 2016. link 6 Unterscheider J, Daly S, Geary MP, Kennelly MM, McAuliffe FM, O'Donoghue K et al.. Definition and management of fetal growth restriction: a survey of contemporary attitudes. European journal of obstetrics, gynecology, and reproductive biology 2014. link 7 Chauhan SP, Dahlke JD, Magann EF, Chang E, Gupta L, Mol BW et al.. Isolated intrauterine growth restriction: a survey of Central Association of Obstetricians Gynecologists (CAOG) members. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2013. link 8 Hodges RJ, Wallace EM. Mending a growth-restricted fetal heart: should we use glucocorticoids?. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2012. link 9 Yajnik CS, Deshmukh US. Fetal programming: maternal nutrition and role of one-carbon metabolism. Reviews in endocrine & metabolic disorders 2012. link 10 Hoffman C, Galan HL. Assessing the 'at-risk' fetus: Doppler ultrasound. Current opinion in obstetrics & gynecology 2009. link 11 Redman CW. The endoplasmic reticulum stress of placental impoverishment. The American journal of pathology 2008. link 12 Bleker OP, Buimer M, van der Post JA, van der Veen F. Ted (G.J.) Kloosterman: on intrauterine growth. The significance of prenatal care. Studies on birth weight, placental weight and placental index. Placenta 2006. link 13 Edouard T, Trivin C, Lawson-Body E, Pinto G, Souberbielle JC, Brauner R. Extreme short stature after intrauterine growth retardation: factors associated with lack of catch-up growth. Hormone research 2004. link 14 Battaglia FC. Current obstetrics: what neonatologists need to know. Acta bio-medica de L'Ateneo parmense : organo della Societa di medicina e scienze naturali di Parma 2000. link 15 Brodszki J, Marsál K. Management of pregnancies with suspected intrauterine growth retardation in Sweden. Results of a questionnaire. Acta obstetricia et gynecologica Scandinavica 2000. link 16 de Onis M, Villar J, Gülmezoglu M. Nutritional interventions to prevent intrauterine growth retardation: evidence from randomized controlled trials. European journal of clinical nutrition 1998. link 17 Boguszewski M, Rosberg S, Albertsson-Wikland K. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children. The Journal of clinical endocrinology and metabolism 1995. link 18 Nienhuis SJ, Zusterzeel NM, Hoogland HJ. Routine clinical policy and application of Doppler measurements in suspected intrauterine growth retardation in university hospitals in The Netherlands. European journal of obstetrics, gynecology, and reproductive biology 1994. link90150-3) 19 Witter FR. Perinatal mortality and intrauterine growth retardation. Current opinion in obstetrics & gynecology 1993. link 20 Meyer L, Bouyer J, Papiernik E, Le Lann D, Moukengue L, Dreyfus J. Secular trend in the rate of small-for-gestational-age infants: Haguenau Study 1971-1985. British journal of obstetrics and gynaecology 1988. link 21 Wennergren M, Karlsson K, Olsson T. A scoring system for antenatal identification of fetal growth retardation. British journal of obstetrics and gynaecology 1982. link 22 Aantaa K, Forss M. Growth of the fetal biparietal diameter in different types of pregnancies. Radiology 1980. link 23 Granat M, Sharf M, Diengott D, Spindel A, Kahana L, Elrad H. Further investigation on the predictive value of human placental lactogen in high-risk pregnancies. American journal of obstetrics and gynecology 1977. link90647-0) 24 Spranger J, Opitz JM, Nourmand A. A new familial intrauterine growth retardation syndrome the "3-M syndrome". European journal of pediatrics 1976. link

Intrauterine hypoxia